BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -100.0% | 1 | -80.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 5 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 5 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | – | 5 | – | 0.00% | – |
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 28 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 28 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | – | 28 | +133.3% | 0.00% | – |
| Q4 2018 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 12 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |